<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-053121</identifier>
<setSpec>0001-6640</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Is intraoperative radiotherapy of valur in the treatment of neuroblastoma?</dc:title>
<dc:description xml:lang="en">Objective: To report our experience with intraoperative radiotherapy (IORT) in the treatment of advanced-stage neuroblastoma in children. Cases report: Seven pediatric patients with a diagnosis of advanced-stage neuroblastoma (stage III and IV) treated with IORT between 1997 and 2004 were reviewed retrospectively. All of them received chemotherapy after biopsy of the tumour mass (HR-NBL ESIOP protocol), with good response. All seven underwent surgical resection of the tumour, with a single IORT dose of 5 to 15 grays. Results: The initial biopsy showed N-mycamplification in all the patients. Chemotherapy was delivered prior to surgical resection. Gross total resection was performed in five patients. In the other two patients, surgery involved only a debulking procedure. Five patients (71,4%) were alive and continued to be disease-free after 44 months of follow-up, with no IORT associated complications. The two patients with unresectable disease had a fatal outcome. Coclucion: total surgical excision is one of the best prognostic factors in advanced-stage neuroblastoma disease. Intraoperative radiotherapy is a safe procedure that appears to enhance local control with improved survival</dc:description>
<dc:creator>Estellés, M. C</dc:creator>
<dc:creator>Parente, A</dc:creator>
<dc:creator>Fanjul, M</dc:creator>
<dc:creator>Vázquez, J</dc:creator>
<dc:creator>Cañizo, A. del</dc:creator>
<dc:creator>Calvo, F</dc:creator>
<dc:creator>Cela, E</dc:creator>
<dc:creator>Laín, A</dc:creator>
<dc:creator>Cerdá, J</dc:creator>
<dc:creator>Cantalejo, A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo: Demostrar la utilidad de la radioterapia intraoperatoria (RIO) en el tratamiento de los niños con neuroblastoma en estadios avanzados. Casos clínicos: Presentamos 7 casos de pacientes con neuroblastoma en estadios III (n=1) y (n=6), con amplificación N-myc en 6 de ellos, tratados desde 1997 hata 2004. Dos de los pacientes presentaron tumores irresecables, con restos tumorales macroscópicos tras la intervención. Resultados: La supervivencia en nuestra serie de pacientes ha sido del 71,4%. No hemos registrado ninguna complicación asociada a la RIO. El tiempo medio de seguimiento es de 44 meses (margen: 7 meses-7 años). En el tratamiento del neuroblastoma de grados III-IV se ha observado una mejora de la supervivencia cuando se controla la enfermedad local primaria. Conclusión: La RIO facilita este control, con la concentración de la radioterapia directamente sobre el lecho tumoral y respetando los campos de irradación colaterales</dc:description>
<dc:source>Acta Pediatr Esp;65(2): 84-86, feb. 2007.</dc:source>
<dc:identifier>ibc-053121</dc:identifier>
<dc:title xml:lang="es">¿Tiene un lugar la radioterapia intraoperatoria en el tratamiento del neuroblastoma?</dc:title>
<dc:subject>^d7399</dc:subject>
<dc:subject>^d6622^s22012</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d28418</dc:subject>
<dc:subject>^d9640^s22059</dc:subject>
<dc:subject>^d32054^s22066</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d9640^s22016</dc:subject>
<dc:subject>^d32054^s22045</dc:subject>
<dc:subject>^d7594^s22066</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d7594^s22045</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d6622^s22016</dc:subject>
<dc:subject>^d11621^s22045</dc:subject>
<dc:subject>^d22226</dc:subject>
<dc:subject>^d9555^s22016</dc:subject>
<dc:subject>^d32054^s22074</dc:subject>
<dc:subject>^d1731^s22045</dc:subject>
<dc:subject>^d9555^s22053</dc:subject>
<dc:subject>^d28998^s22045</dc:subject>
<dc:type>article</dc:type>
<dc:date>200702</dc:date>
</metadata>
</record>
</ibecs-document>
